Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

05. Januar 2007 13:00 ET | Quelle: Talon Therapeutics, Inc.

Hana Biosciences Announces Vice President Appointments in Clinical Operations and Corporate Development

SOUTH SAN FRANCISCO, Calif., Jan. 5, 2007 (PRIME NEWSWIRE) -- Hana Biosciences (Nasdaq:HNAB), a biopharmaceutical company focused on advancing cancer care, today announced the promotion of Gavin S....
08. Dezember 2006 14:26 ET | Quelle: Talon Therapeutics, Inc.

Hana Biosciences Announces Data to be Presented On Talvesta (talotrexin) for Injection and Marqibo (vincristine sulfate liposomes injection) At the American Society of Hematology Annual Meeting

SOUTH SAN FRANCISCO, Calif., Dec. 8, 2006 (PRIME NEWSWIRE) -- Hana Biosciences (Nasdaq:HNAB), a biopharmaceutical company focused on advancing cancer care, will present data from the completed Phase I...
01. Dezember 2006 14:03 ET | Quelle: Talon Therapeutics, Inc.

Hana Biosciences to Present at the BMO Capital Markets Focus on Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Dec. 1, 2006 (PRIME NEWSWIRE) -- Hana Biosciences (Nasdaq:HNAB), a biopharmaceutical company focused on advancing cancer care, announced today that Mark Ahn, PhD,...
21. November 2006 19:24 ET | Quelle: Talon Therapeutics, Inc.

Hana Biosciences to Present at the Lazard Capital Markets 3rd Annual Life Science Conference

SOUTH SAN FRANCISCO, Nov. 21, 2006 (PRIMEZONE) -- Hana Biosciences (Nasdaq:HNAB), a biopharmaceutical company focused on advancing cancer care, announced today that Mark Ahn, PhD, President &...
02. November 2006 16:20 ET | Quelle: Talon Therapeutics, Inc.

Hana Biosciences Announces Third Quarter 2006 Results

SAN FRANCISCO, Nov. 2, 2006 (PRIMEZONE) -- Hana Biosciences (Nasdaq:HNAB), a biopharmaceutical company focused on advancing cancer care, today announced financial results for the third quarter of...
31. Oktober 2006 13:58 ET | Quelle: Talon Therapeutics, Inc.

Hana Biosciences to Present At the Rodman & Renshaw 8th Annual Healthcare Conference

SAN FRANCISCO, Oct. 31, 2006 (PRIMEZONE) -- Hana Biosciences (Nasdaq:HNAB), a biopharmaceutical company focused on advancing cancer care, announced today that Mark Ahn, PhD, President & Chief...
31. Oktober 2006 07:03 ET | Quelle: Talon Therapeutics, Inc.

Hana Biosciences Initiates Phase II Trial of Talvesta (talotrexin) for Injection in Acute Lymphoblastic Leukemia

SOUTH SAN FRANCISCO, Calif., Oct. 31, 2006 (PRIMEZONE) -- Hana Biosciences (Nasdaq:HNAB), a biopharmaceutical company focused on advancing cancer care, today announced the initiation of a multicenter...